• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Exploring the unexplored: identifying knowledge gaps in novel pharmacological treatments for diabetic retinopathy.探索未知领域：识别糖尿病视网膜病变新型药物治疗中的知识空白。
Eye (Lond). 2025 Jan;39(1):192-194. doi: 10.1038/s41433-024-03349-x. Epub 2024 Sep 17.
2
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较：一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
3
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较：一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
4
Fenofibrate for diabetic retinopathy.非诺贝特治疗糖尿病性视网膜病变。
Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2.
5
Aspirin in diabetic retinopathy. A systematic review.
Endocrinol Metab Clin North Am. 2002 Sep;31(3):779-93. doi: 10.1016/s0889-8529(02)00017-8.
6
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制。
Cochrane Database Syst Rev. 2023 Mar 28;3(3):CD006127. doi: 10.1002/14651858.CD006127.pub3.
7
Prevalence of Diabetic Retinopathy in Indigenous and Non-Indigenous Australians: A Systematic Review and Meta-analysis.澳大利亚原住民和非原住民糖尿病视网膜病变的患病率：系统评价与荟萃分析
Ophthalmology. 2023 Jan;130(1):56-67. doi: 10.1016/j.ophtha.2022.07.024. Epub 2022 Aug 2.
8
A systematic literature review of machine learning based risk prediction models for diabetic retinopathy progression.基于机器学习的糖尿病视网膜病变进展风险预测模型的系统文献回顾。
Artif Intell Med. 2023 Sep;143:102617. doi: 10.1016/j.artmed.2023.102617. Epub 2023 Jun 26.
9
Pentoxifylline for diabetic retinopathy.己酮可可碱用于治疗糖尿病视网膜病变。
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD006693. doi: 10.1002/14651858.CD006693.pub2.
10
Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review.基于网络药理学和文献回顾的芪明颗粒治疗糖尿病视网膜病变的药理机制及临床研究。
J Ethnopharmacol. 2023 Feb 10;302(Pt A):115861. doi: 10.1016/j.jep.2022.115861. Epub 2022 Nov 2.

引用本文的文献

1
SGLT2 inhibitors and diabetic retinopathy: Insights from the management of nephropathy.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病视网膜病变：来自肾病管理的见解
Eye (Lond). 2025 Feb;39(2):213-214. doi: 10.1038/s41433-024-03472-9. Epub 2024 Nov 12.

本文引用的文献

1
An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma.后部阶段慢性致盲性眼病长效治疗的最新进展：AMD、DMO、RVO、葡萄膜炎和青光眼。
Eye (Lond). 2022 Jun;36(6):1154-1167. doi: 10.1038/s41433-021-01766-w. Epub 2022 Jan 1.
2
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.

Exploring the unexplored: identifying knowledge gaps in novel pharmacological treatments for diabetic retinopathy.

作者信息

Sharifan Amin, Sivaprasad Sobha

机构信息

Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems an der Donau, Austria.

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.

出版信息

Eye (Lond). 2025 Jan;39(1):192-194. doi: 10.1038/s41433-024-03349-x. Epub 2024 Sep 17.

DOI:10.1038/s41433-024-03349-x
PMID:39289518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11733177/
Abstract
摘要